These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36612433)

  • 1. The 8-Week Efficacy of Frequency Rhythmic Electrical Modulated System (FREMS) as an Add-on Therapy in the Treatment of Symptomatic Diabetic Peripheral Polyneuropathy.
    Gorczyca-Siudak D; Dziemidok P
    Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial.
    Bosi E; Bax G; Scionti L; Spallone V; Tesfaye S; Valensi P; Ziegler D;
    Diabetologia; 2013 Mar; 56(3):467-75. PubMed ID: 23238789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency Rhythmic Electrical Modulation System (FREMS) to alleviate painful diabetic peripheral neuropathy: A pilot, randomised controlled trial (The FREMSTOP study).
    Crasto W; Altaf QA; Selvaraj DR; Jack B; Patel V; Nawaz S; Murthy N; Sukumar N; Saravanan P; Tahrani AA
    Diabet Med; 2022 Mar; 39(3):e14710. PubMed ID: 34605077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of frequency-modulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy.
    Bosi E; Conti M; Vermigli C; Cazzetta G; Peretti E; Cordoni MC; Galimberti G; Scionti L
    Diabetologia; 2005 May; 48(5):817-23. PubMed ID: 15834546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.
    Ziegler D; Hanefeld M; Ruhnau KJ; Hasche H; Lobisch M; Schütte K; Kerum G; Malessa R
    Diabetes Care; 1999 Aug; 22(8):1296-301. PubMed ID: 10480774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review.
    Ziegler D
    Treat Endocrinol; 2004; 3(3):173-89. PubMed ID: 16026113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of α-lipoic acid on symptoms and quality of life in patients with painful diabetic neuropathy.
    Agathos E; Tentolouris A; Eleftheriadou I; Katsaouni P; Nemtzas I; Petrou A; Papanikolaou C; Tentolouris N
    J Int Med Res; 2018 May; 46(5):1779-1790. PubMed ID: 29517942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.
    Ziegler D; Reljanovic M; Mehnert H; Gries FA
    Exp Clin Endocrinol Diabetes; 1999; 107(7):421-30. PubMed ID: 10595592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).
    Ziegler D; Hanefeld M; Ruhnau KJ; Meissner HP; Lobisch M; Schütte K; Gries FA
    Diabetologia; 1995 Dec; 38(12):1425-33. PubMed ID: 8786016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT.
    Tesfaye S; Sloan G; Petrie J; White D; Bradburn M; Young T; Rajbhandari S; Sharma S; Rayman G; Gouni R; Alam U; Julious SA; Cooper C; Loban A; Sutherland K; Glover R; Waterhouse S; Turton E; Horspool M; Gandhi R; Maguire D; Jude E; Ahmed SH; Vas P; Hariman C; McDougall C; Devers M; Tsatlidis V; Johnson M; Bouhassira D; Bennett DL; Selvarajah D
    Health Technol Assess; 2022 Oct; 26(39):1-100. PubMed ID: 36259684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of vascular endothelial growth factor release by transcutaneous frequency modulated neural stimulation in diabetic polyneuropathy.
    Bevilacqua M; Dominguez LJ; Barrella M; Barbagallo M
    J Endocrinol Invest; 2007 Dec; 30(11):944-7. PubMed ID: 18250616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with thioctacid (thioctic acid) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients.
    Hahm JR; Kim BJ; Kim KW
    J Diabetes Complications; 2004; 18(2):79-85. PubMed ID: 15120701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis.
    Ziegler D; Nowak H; Kempler P; Vargha P; Low PA
    Diabet Med; 2004 Feb; 21(2):114-21. PubMed ID: 14984445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy.
    Reljanovic M; Reichel G; Rett K; Lobisch M; Schuette K; Möller W; Tritschler HJ; Mehnert H
    Free Radic Res; 1999 Sep; 31(3):171-9. PubMed ID: 10499773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative double-blind randomized study on the effectiveness of Duloxetine and Gabapentin on painful diabetic peripheral polyneuropathy.
    Majdinasab N; Kaveyani H; Azizi M
    Drug Des Devel Ther; 2019; 13():1985-1992. PubMed ID: 31354243
    [No Abstract]   [Full Text] [Related]  

  • 16. Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy.
    Rolim LC; da Silva EM; Flumignan RL; Abreu MM; Dib SA
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD011265. PubMed ID: 31201734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregabalin for neuropathic pain in adults.
    Derry S; Bell RF; Straube S; Wiffen PJ; Aldington D; Moore RA
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD007076. PubMed ID: 30673120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation.
    Duarte RV; Andronis L; Lenders MW; de Vos CC
    Qual Life Res; 2016 Jul; 25(7):1771-7. PubMed ID: 26694963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. γ-Linolenic Acid versus α-Lipoic Acid for Treating Painful Diabetic Neuropathy in Adults: A 12-Week, Double-Placebo, Randomized, Noninferiority Trial.
    Won JC; Kwon HS; Moon SS; Chun SW; Kim CH; Park IB; Kim IJ; Lee J; Cha BY; Park TS
    Diabetes Metab J; 2020 Aug; 44(4):542-554. PubMed ID: 31701699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NRD.E1, an innovative non-opioid therapy for painful diabetic peripheral neuropathy-A randomized proof of concept study.
    Tiecke E; Rainisio M; Eisenberg E; Wainstein J; Kaplan E; Silverberg M; Hochman L; Mangialaio S
    Eur J Pain; 2022 Sep; 26(8):1665-1678. PubMed ID: 35671086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.